Tracey is a widow with two middle-school-aged children. For the past several years she has worked very successfully as a mid-level manager for a large, transnational pharmaceutical corporation, making a salary of approximately $90,000 per annum. She is proud of her work and proud to be affiliated with such a prestigious employer.
Her company has recently completed phase II of its animal testing on a promising new cancer drug. The successful development and commercialization of this drug is a key component in the company’s strategic growth plan. Before the company can move from the animal testing stage to human trials the Food and Drug Administration (FDA) must review and approve the animal testing results and give the okay for the human trials. Without human trials the drug has no chance of making it to market.
This morning, Tracey’s boss called her to a private meeting in his office. After reiterating how important the success of the cancer drug trials is to the future of the company, he directed her to change some figures related to the percentage of animals that died as a result of receiving injections of the cancer drug during the phase II trials. Specifically, he told Tracey that her report to the FDA will have to show a percentage of animal deaths that is 10% lower than the actual rate of deaths the raw data in the test results indicate.
Based on the above, respond to each of the following:
What are Tracey's obligations as an agent of the company?
Analyze the ethics of the situation using the approach outlined in Badaracco's framework. Be sure to support your analysis through sound reasoning, incorporating appropriate ethical principles and theories.
Based on your legal and ethical analysis, advise Tracey on what she should do. Identify her main options, then tell her which she should choose, and why.
Which way of proceeding is going to get the best net-net consequences?
Whose rights must be respected?
Does the plan jeopardize the individual or the organization’s integrity?
Massive Corporation is a technology-manufacturing firm with more than 135,000 employees in its worldwide operations. It currently does business in 85 countries and generates more than $25 billion in revenue. Among its many products are hydroelectric power generators, freight rail cars, computer assembly robotics, and atomic energy plant process controls. The nature of these and its other high-tech products makes it critically important that Massive be on the cutting edge of innovation and that it leverage to the extent possible economies of scale in its research/development and production processes. Massive’s customers pay top-dollar for these big-ticket products, so they are demanding in terms of having the most up-to-date and best-functioning technology.